The Genetics Company, Inc. opened the first of several reference centers for Alzheimer's disease diagnostics and patient care
15-Oct-2004 -
The Genetics Company, Inc. a privately held
Swiss drug discovery and development company, focusing on the research, development
and commercialization of products for the diagnosis, monitoring and therapy of patients
suffering from Alzheimer's disease and cancer, opened the first of several ...
Alzheimer's disease
biochemistry
clinical trials
+4